1. Long-term impact of COVID-19 among maintenance haemodialysis patients
- Author
-
Albert Buchard, Laurence Nicolet, Karim Dardim, Sylvain Chawki, Hamza Sakhi, Remy Boula, Abderrahmane Ghazali, Rachida Nebbad, Philippe Rieu, Luc Fromentin, Frederic Besson, Mohamad-Khair Rifard, Adem Arezki, Afshin Masoumi, Henri Boulanger, Julie Sohier-Attias, Tomek Kofman, Jean-François Desassis, Mokhtar Chawki, Patrick Michaut, Salima Ahriz-Saksi, Ali Hafi, Emmanuel Dupuis, Ali Zineddine Diddaoui, David Attaf, Karim El Sakhawi, Khalil El Karoui, Philippe Attias, Dominique Joly, Larbi Lamriben, and Djamal Dahmane
- Subjects
Transplantation ,medicine.medical_specialty ,hemodialysis ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,business.industry ,COVID-19 ,long-term follow-up ,Maintenance hemodialysis ,cachexia ,mortality ,Term (time) ,nutritional status ,Nephrology ,medicine ,Original Article ,AcademicSubjects/MED00340 ,Intensive care medicine ,business - Abstract
Background Maintenance haemodialysis (MHD) patients have a high risk of initial mortality from coronavirus disease 2019 (COVID-19). However, long-term consequences of this disease in the MHD population are poorly described. We report the clinical presentation, outcome and long-term follow-up of MHD patients affected by COVID-19 in a multicentric cohort from the Paris, France area. Methods We conducted a retrospective analysis of clinical presentation and long-term follow-up of MHD patients affected by COVID-19 in 19 MHD centres in the Paris, France area. Results In this cohort of 248 patients with an initial mortality rate of 18%, age, comorbidities, dyspnoea and previous immunosuppressive treatment were associated with death at Conclusions This work demonstrates the long-term consequences of COVID-19 in MHD patients, highlighting both initial and long-term severity of the disease, including severe cachexia.
- Published
- 2021